{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:04:05Z","timestamp":1760234645029,"version":"build-2065373602"},"reference-count":21,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-FAR\/31598\/2017"],"award-info":[{"award-number":["PTDC\/MED-FAR\/31598\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Aging-related loss of resilience associated with the lack of evidence regarding the therapeutic efficacy of medicines can prompt a lack of efficacy of treatments and multiple prescriptions. This work aims to characterize the medication profile of Portuguese older adult inpatients and explore the relationship between hospitalization days and the consumption of medicines. A retrospective data analysis study in older patients who were admitted to a medical internal medicine ward during 2019. The median age of the 616 patients included was 85 years. During the hospitalized period, patients took on average 18.08 medicines. The most prescribed drugs belong to the subgroup of (a) anti-thrombotic agents (6.7%), with enoxaparin being the most prescribed, (b) other analgesics and antipyretics (6.6%), paracetamol being the most frequent, and (c) the Angiotensin Conversion Enzyme Inhibitor (ACE) (6.5%), captopril being the most frequent. The high number of prescriptions in older adults during their hospitalization suggests the need of changing therapeutics to achieve a better efficacy of treatment, which corroborates the hypothesis that the lack of scientific evidence concerning the risk\/benefits of many medical therapies in older adults can make it difficult to achieve good clinical outcomes and promote the wastage of health resources.<\/jats:p>","DOI":"10.3390\/healthcare9060704","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:31:39Z","timestamp":1623331899000},"page":"704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profile of Prescription Medication in an Internal Medicine Ward"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-3770","authenticated-orcid":false,"given":"Carla","family":"Perp\u00e9tuo","sequence":"first","affiliation":[{"name":"Research Unit for Inland Development, Polytechnic Institute of Guarda (UDI-IPG), 6300-559 Guarda, Portugal"},{"name":"Local Health Unit of Guarda, 6300-035 Guarda, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Pl\u00e1cido","sequence":"additional","affiliation":[{"name":"Local Health Unit of Guarda, 6300-035 Guarda, Portugal"},{"name":"Institute of Biomedicine (iBiMED-UA), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Aperta","sequence":"additional","affiliation":[{"name":"Research Unit for Inland Development, Polytechnic Institute of Guarda (UDI-IPG), 6300-559 Guarda, Portugal"},{"name":"Local Health Unit of Guarda, 6300-035 Guarda, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-4049","authenticated-orcid":false,"given":"Maria Teresa","family":"Herdeiro","sequence":"additional","affiliation":[{"name":"Institute of Biomedicine (iBiMED-UA), Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0169-3788","authenticated-orcid":false,"given":"F\u00e1tima","family":"Roque","sequence":"additional","affiliation":[{"name":"Research Unit for Inland Development, Polytechnic Institute of Guarda (UDI-IPG), 6300-559 Guarda, Portugal"},{"name":"Health Science Research Center (CICS-UBI), University of Beira Interior, 6201-001 Covilh\u00e3, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"ref_1","unstructured":"United Nations (2019). World Population Ageing 2019 Highlights, United Nations."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1183\/09031936.00059814","article-title":"Ageing and the epidemiology of multimorbidity","volume":"44","author":"Divo","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jcpt.12494","article-title":"The use of potentially inappropriate medications among the Lithuanian elderly according to Beers and EU (7)-PIM list\u2014A nationwide cross-sectional study on reimbursement claims data","volume":"42","author":"Grina","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arr.2010.04.005","article-title":"Geriatric drug therapy: Neglecting the inevitable majority","volume":"9","author":"Stegemann","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.32385\/rpmgf.v29i1.11048","article-title":"Deprescribing no idoso","volume":"29","author":"Martins","year":"2013","journal-title":"Rev. Port. Cl\u00ednica Geral"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lee, E.A., Brettler, J.W., Kanter, M.H., Steinberg, S.G., Khang, P., Distasio, C.C., Martin, J., Dreskin, M., Thompson, N.H., and Cotter, T.M. (2020). Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit. Perm. J., 24.","DOI":"10.7812\/TPP\/18.212"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/bcp.12596","article-title":"Adverse drug reactions in special populations\u2014The elderly","volume":"80","author":"Davies","year":"2015","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1001\/archinte.164.18.1957","article-title":"Polypharmacy: A new paradigm for quality drug therapy in the elderly?","volume":"164","author":"Gurwitz","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.archger.2017.05.017","article-title":"A systematic review of trends in the selective exclusion of older participant from randomised clinical trials","volume":"72","author":"Thake","year":"2017","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_10","unstructured":"(2021, February 02). WHO Collaborating Centre for Drug Statistics Methodology\u2014ATC\/DDD. Available online: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chocano-Bedoya, P.O., and Bischoff-Ferrari, H.A. (2019). DO-HEALTH: Vitamin D3-Omega-3-Home Exercise-Healthy Aging and Longevity Trial\u2014Dietary Patterns in Five European Countries, Springer.","DOI":"10.1007\/978-3-319-98464-3_1"},{"key":"ref_12","first-page":"205","article-title":"Interventions to optimize pharmacologic treatment in hospitalized older adults: A systematic review","volume":"216","author":"Tosato","year":"2016","journal-title":"Rev. Clin. Esp."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Abegaz, T.M., Birru, E.M., and Mekonnen, G.B. (2018). Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders using START\/STOPP criteria. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195949"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ejhpharm-2017-001262","article-title":"Applicability of the STOPP\/START criteria to older polypathological patients in a long-term care hospital","volume":"25","year":"2018","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00228-015-1860-9","article-title":"The EU(7)-PIM list: A list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"71","author":"Meyer","year":"2015","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fahrni, M.L., Azmy, M.T., Usir, E., Aziz, N.A., and Hassan, Y. (2019). Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0219898"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ageing\/afs046","article-title":"Adverse drug reactions in older patients during hospitalisation: Are they predictable?","volume":"41","author":"Gallagher","year":"2012","journal-title":"Age Ageing"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/jcpt.12638","article-title":"A comparison of two tools to screen potentially inappropriate medication in internal medicine patients","volume":"43","author":"Blanc","year":"2018","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/CIA.S190983","article-title":"Comparison of three criteria for potentially inappropriate medications in chinese older adults","volume":"14","author":"Ma","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/bcp.14074","article-title":"The clinical and therapeutic challenge of treating older patients in clinical practice","volume":"86","author":"Thurner","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019with network analysis: Implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/6\/704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:47Z","timestamp":1760163167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/6\/704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["healthcare9060704"],"URL":"https:\/\/doi.org\/10.3390\/healthcare9060704","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}